Stay updated on COMBAT-CRPC: Bipolar Androgen Therapy and Nivolumab Clinical Trial
Sign up to get notified when there's something new on the COMBAT-CRPC: Bipolar Androgen Therapy and Nivolumab Clinical Trial page.

Latest updates to the COMBAT-CRPC: Bipolar Androgen Therapy and Nivolumab Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe COMBAT-CRPC Phase II study record is displayed with its study details, eligibility criteria, treatment plan, locations, outcome measures, and supporting documents.SummaryDifference64%

- Check15 days agoChange DetectedThe footer’s revision identifier changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check22 days agoChange DetectedA banner was added announcing an NIH-wide transition from “Artificial Intelligence” to “Super Intelligence” terminology and linking to updates and FAQs.SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check43 days agoChange DetectedThe study record page is showing a 403 Forbidden message with a Home link instead of its study details.SummaryDifference0.5%

Stay in the know with updates to COMBAT-CRPC: Bipolar Androgen Therapy and Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the COMBAT-CRPC: Bipolar Androgen Therapy and Nivolumab Clinical Trial page.